03/05/2021 | Press release | Distributed by Public on 03/05/2021 14:47
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
Cover
Cover |
12 Months Ended |
---|---|
Dec. 31, 2020 shares |
|
Cover [Abstract] | |
Entity Registrant Name | ONCOLYTICS BIOTECH INC |
Entity Central Index Key | 0001129928 |
Current Fiscal Year End Date | --12-31 |
Entity Filer Category | Accelerated Filer |
Document Type | 20-F |
Document Period End Date | Dec. 31, 2020 |
Document Fiscal Year Focus | 2020 |
Document Fiscal Period Focus | FY |
Amendment Flag | false |
Entity Common Stock, Shares Outstanding | 46,166,980 |
ICFR Auditor Attestation Flag | true |
Entity Shell Company | false |
Entity Emerging Growth Company | false |
Entity Well-known Seasoned Issuer | No |
Entity Voluntary Filers | No |
Entity Current Reporting Status | Yes |